Literature DB >> 33947330

Prevalence, population structure, distribution of serotypes, pilus islands and resistance genes among erythromycin-resistant colonizing and invasive Streptococcus agalactiae isolates recovered from pregnant and non-pregnant women in Isfahan, Iran.

Tahereh Motallebirad1, Hossein Fazeli1, Ataollah Ghahiri2, Dariush Shokri3, Saba Jalalifar1, Sharareh Moghim1, Bahram Nasr Esfahani4.   

Abstract

BACKGROUND: The information on antibiotic resistance and molecular features of Group B Streptococcus (GBS) are essential for epidemiological purposes as well as vaccine development. Therefore, we aimed to assess the antimicrobial resistance profiles and molecular characteristics of GBS isolates in Isfahan, Iran. A total number of 72 colonizing and invasive GBS were collected from pregnant and non-pregnant women. The GBS isolates were analyzed for resistance profiles, capsular genotyping, and detection of PI-1, PI-2a, PI-2b, hvgA, ermB, ermTR, lnuB and, mefA genes. Besides, erythromycin-resistant strains were subjected to multilocus sequence typing (MLST).
RESULTS: The prevalence of colonizing and invasive GBS were 11 and 0.05%, respectively. The frequency of capsular serotypes was as follows: III (26.3%), Ia (20.83%), Ib and V (each 15.2%), IV (9.7%), II (8.3%), VII (2.7%), and VI (1.3%). Overall frequencies of PIs were as follows: PI-1, 37.5%, PI-1 + PI-2a, 30.5%, PI-1 + PI-2b, 29.1% and PI-2b, 2.7%. Two maternal colonizing GBS (2.6%) were hvgA positive and were belonged to ST-17/CPS-III/PI-1 + PI-2b lineage. Among 30(41.6%) erythromycin resistant GBS, 21 isolates (70%) harbored ermB gene, followed by ermTR (23.3%) and mefA (10%). One clindamycin-resistant isolate harbored the lnuB gene. MLST analysis revealed the following five clonal complexes (CCs) and nine STs: (CC-19/ST-335, ST-19, and ST-197), (CC-12/ST-43, ST-12), (CC-23/ST-163, ST-23), (CC-17/ST-17) and (CC-4/ST-16).
CONCLUSION: The study shows an alarmingly high prevalence of erythromycin-resistant GBS in Iran. In addition, we report dissemination of ST-335/CPS-III clone associated with tetracycline and erythromycin resistance in our region. The distribution of capsular and pilus genotypes varies between invasive and colonizing GBS that could be helpful for vaccine development.

Entities:  

Keywords:  Antibiotic susceptibility; Capsular genotyping; Iran; MLST; Pilus islands; Streptococcus agalactiae

Year:  2021        PMID: 33947330     DOI: 10.1186/s12866-021-02186-2

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


  47 in total

1.  Molecular characterization and antimicrobial susceptibility of hemolytic Streptococcus agalactiae from post-menopausal women.

Authors:  Belén Moltó-García; María del Carmen Liébana-Martos; Elena Cuadros-Moronta; Javier Rodríguez-Granger; Antonio Sampedro-Martínez; Manuel Rosa-Fraile; José Gutierrez-Fernández; Alberto Puertas-Priet; José María Navarro-Marí
Journal:  Maturitas       Date:  2015-11-26       Impact factor: 4.342

2.  Prevention of Group B streptococcus infection.

Authors:  Nan-Chang Chiu
Journal:  Pediatr Neonatol       Date:  2019-05-04       Impact factor: 2.083

Review 3.  Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Clin Microbiol Rev       Date:  2018-08-15       Impact factor: 26.132

4.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 5.  Group B Streptococcus: global incidence and vaccine development.

Authors:  Atul Kumar Johri; Lawrence C Paoletti; Philippe Glaser; Meenakshi Dua; Puja Kumari Sharma; Guido Grandi; Rino Rappuoli
Journal:  Nat Rev Microbiol       Date:  2006-11-06       Impact factor: 60.633

6.  Molecular characteristics and antimicrobial resistance in invasive and noninvasive Group B Streptococcus between 2008 and 2015 in China.

Authors:  Binghuai Lu; Xingchun Chen; Junrui Wang; Duochun Wang; Ji Zeng; Yi Li; Dong Li; Fengxia Zhu; Yanchao Cui; Lei Huang
Journal:  Diagn Microbiol Infect Dis       Date:  2016-08-28       Impact factor: 2.803

Review 7.  An overview of global GBS epidemiology.

Authors:  Kirsty Le Doare; Paul T Heath
Journal:  Vaccine       Date:  2013-08-28       Impact factor: 3.641

8.  Evaluation of procedures for typing of group B Streptococcus: a retrospective study.

Authors:  Hans-Christian Slotved; Steen Hoffmann
Journal:  PeerJ       Date:  2017-03-16       Impact factor: 2.984

9.  Group B streptococcus infections of soft tissue and bone in California adults, 1995-2012.

Authors:  E M Smith; M A Khan; A Reingold; J P Watt
Journal:  Epidemiol Infect       Date:  2015-11       Impact factor: 4.434

10.  Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis.

Authors:  Mucheye Gizachew; Moges Tiruneh; Feleke Moges; Mulat Adefris; Zemene Tigabu; Belay Tessema
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-01-19       Impact factor: 3.944

View more
  1 in total

1.  Emerging Fatal Ib/CC12 Hypervirulent Multiresistant Streptococcus agalactiae in Young Infants With Bloodstream Infection in China.

Authors:  Jingxian Liu; Feng Chen; Hongyan Guan; Jiajia Yu; Jing Yu; Jing Zhao; Ying Liu; Lisong Shen
Journal:  Front Microbiol       Date:  2021-12-15       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.